BioSante Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer Vaccine
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX Pancreas Vaccine in the treatment of pancreatic cancer. “The Orphan Drug designation of GVAX Pancreas Vaccine for the treatment of pancreatic cancer is BioSante’s first GVAX regulatory submission and response from the FDA since …
Source: Read more on PharmaceuticalOnline
Swine Flu symptom vaccine fact epidemic vaccination tip
 | US $3.49 End Date: Wednesday Feb-15-2012 14:03:33 PST Buy It Now for only: US $3.49 Buy it now | Add to watch list |
